TheraVet SA

ISIN: BE0974387194 | Ticker: ALVET | LEI: 984500804EBR3F1EFF71

Sector: Health Care – Sub-Industry: Pharmaceuticals

Country: Belgium

About TheraVet SA

Company Description

TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.

TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases.

TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.

TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.

Year founded

2017

Served area

Worldwide

Headquarters

Avenue Jean Mermoz 32/1, 6041 Charleroi, Hainaut – Belgium